Zhejiang
603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd. Price (603896.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
195,753,891
(1.6677)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.Currency: CNY
| YEAR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
177.75M
+0% |
253.03M
+42% |
301.59M
+19% |
301.91M
+0% |
314.88M
+4% |
369.96M
+17% |
511.45M
+38% |
546.76M
+7% |
636.05M
+16% |
767.14M
+21% |
829.07M
+8% |
784.35M
-5% |
|||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 76.38M | 87.86M | 82.15M | 57.47M | 47.58M | 50.93M | 72.06M | 85.41M | 105.67M | 126.37M | 129.21M | 135.53M | |||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
101.37M
+0% |
165.17M
+63% |
219.44M
+33% |
244.45M
+11% |
267.30M
+9% |
319.03M
+19% |
439.39M
+38% |
461.35M
+5% |
530.38M
+15% |
640.76M
+21% |
699.86M
+9% |
648.82M
-7% |
|||||||
| Gross Profit Ratio | (0.57%) | (0.65%) | (0.73%) | (0.81%) | (0.85%) | (0.86%) | (0.86%) | (0.84%) | (0.83%) | (0.84%) | (0.84%) | (0.83%) | |||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 9.00M | 12.70M | 20.55M | 17.95M | 17.81M | 20.97M | 33.67M | 39.42M | 48.49M | 50.82M | 47.82M | 49.68M | |||||||
| General and Administrative | 23.37M | 33.11M | 13.91M | 12.01M | 12.44M | 18.39M | 53.09M | 58.98M | 44.99M | 35.67M | 37.19M | 43.93M | |||||||
| Selling, General & Admin... | 68.11M | 105.83M | 117.75M | 140.08M | 151.24M | 196.95M | 289.59M | 292.63M | 309.01M | 355.43M | 356.57M | 360.73M | |||||||
| Selling & Marketing Exp... | 44.73M | 72.72M | 103.84M | 128.07M | 138.79M | 178.56M | 236.50M | 233.65M | 264.02M | 319.76M | 319.37M | 316.79M | |||||||
| Depreciation and Amortiz... | 1.40M | 8.32M | 20.84M | 35.42M | 114.07M | 39.88M | 47.07M | 49.13M | 54.70M | 65.83M | 81.08M | 99.99M | |||||||
| Other Expenses | 4.10M | 2.37M | 3.23M | 5.26M | 9.94M | -2,046,041.83 | -216,796.00 | 15.32M | 16.68M | 34.55M | 28.12M | -58,155,923.00 | |||||||
| Total Operating Expenses | 68.96M | 107.37M | 155.42M | 181.08M | 191.37M | 233.31M | 339.96M | 347.37M | 374.18M | 440.81M | 432.51M | 394.10M | |||||||
| Cost and Exponses | 145.34M | 195.24M | 237.58M | 238.55M | 238.94M | 284.24M | 412.02M | 432.77M | 479.85M | 567.18M | 561.71M | 529.62M | |||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
30.83M
+0% |
52.65M
+71% |
66.45M
+26% |
57.50M
-13% |
71.01M
+24% |
90.84M
+28% |
110.30M
+21% |
127.77M
+16% |
158.90M
+24% |
207.15M
+30% |
280.88M
+36% |
254.72M
-9% |
|||||||
| Operating Income Ratio | (0.17%) | (0.21%) | (0.22%) | (0.19%) | (0.23%) | (0.25%) | (0.22%) | (0.23%) | (0.25%) | (0.27%) | (0.34%) | (0.32%) | |||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 196.59k | 125.91k | 24.62k | 600.48k | 1.90M | 3.33M | 11.51M | 24.16M | 25.45M | 48.09M | |||||||
| Interest Expenses | 1.63M | 1.78M | 1.61M | 7.97M | 6.85M | 1.91M | 969.11k | 978.99k | 11.72M | 10.17M | 13.03M | 25.05M | |||||||
| Total Other Income/Exp... | 2.49M | 2.37M | 3.08M | 5.13M | 9.94M | -2,046,042.00 | -216,796.00 | -2,780,175.00 | -5,202,272.00 | -6,092,543.00 | -2,912,799.00 | 188.56k | |||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 33.67M | 60.98M | 87.55M | 98.54M | 202.54M | 131.16M | 158.29M | 175.67M | 220.73M | 278.36M | 372.71M | 379.58M | |||||||
| EBITDA ratio | (0.18%) | (0.24%) | (0.30%) | (0.35%) | (0.40%) | (0.34%) | (0.30%) | (0.31%) | (0.33%) | (0.35%) | (0.43%) | (0.48%) | |||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 34.90M | 55.02M | 69.53M | 62.62M | 80.93M | 88.79M | 110.09M | 124.99M | 153.70M | 201.06M | 277.97M | 254.91M | |||||||
| Income Before Tax Ratio | (0.20%) | (0.22%) | (0.23%) | (0.21%) | (0.26%) | (0.24%) | (0.22%) | (0.23%) | (0.24%) | (0.26%) | (0.34%) | (0.32%) | |||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 874.82k | 971.62k | 278.26k | -21,142.80 | -50,621.13 | -88,851.04 | 2.44M | 1.10M | 1.99M | 749.29k | 452.57k | 430.87k | |||||||
| Net Income | |||||||||||||||||||
| Net Income | 34.02M
+0% |
54.05M
+59% |
69.25M
+28% |
62.64M
-10% |
80.98M
+29% |
88.88M
+10% |
107.65M
+21% |
123.90M
+15% |
151.71M
+22% |
200.83M
+32% |
277.78M
+38% |
254.48M
-8% |
|||||||
| Net Income Ratio | (0.19%) | (0.21%) | (0.23%) | (0.21%) | (0.26%) | (0.24%) | (0.21%) | (0.23%) | (0.24%) | (0.26%) | (0.34%) | (0.32%) | |||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.32 | 0.40 | 0.51 | 0.46 | 0.59 | 0.55 | 0.59 | 0.68 | 0.82 | 1.04 | 1.44 | 1.30 | |||||||
| Diluted EPS | 0.32 | 0.40 | 0.51 | 0.46 | 0.59 | 0.55 | 0.58 | 0.68 | 0.82 | 1.04 | 1.44 | 1.30 | |||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 104.93M | 104.93M | 136.40M | 135.73M | 136.72M | 162.72M | 181.74M | 183.03M | 184.32M | 193.59M | 192.54M | 195.75M | |||||||
| Diluted Share Outstanding | 104.93M | 104.93M | 136.40M | 135.73M | 136.72M | 162.74M | 184.14M | 183.03M | 184.32M | 193.59M | 192.54M | 195.75M | |||||||